Skip to content
Use caution Drug recall · FDA · Published January 14, 2026

Oxycodone 5mg Tablets Recall: Weak Blister Seals Cause Tablets to Fall Out

Amerisource Health Services recalls 5mg oxycodone tablets with weak blister seals that may cause tablets to fall out. Stop using if you have these specific packaging.

🇺🇸 FDA recall #D-0338-2026DrugAmerisource Health Services ›
Take action

Contact the company

Recalling firmAmerisource Health Services LLC2550 John Glenn Ave Ste A · Columbus, OH 43217-1188
✎ GovInfoNow plain-language explainer

Amerisource Health Services is recalling 5mg oxycodone tablets that may have weak blister seals. This could cause tablets to fall out of their packaging, increasing the risk of accidental ingestion or injury. Read more at govinfonow.com/recall/31554-oxycodone-5mg-tablets-recall-weak-blister-seals-cause-tablets-to.

Source Summary by GovInfoNow · govinfonow.com/recall/31554-oxycodone-5mg-tablets-recall-weak-blister-seals-cause-tablets-to · Updated August 17, 2026 · FDA enforcement record: FDA #D-0338-2026

Cite this page

“Oxycodone 5mg Tablets Recall: Weak Blister Seals Cause Tablets to Fall Out.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31554-oxycodone-5mg-tablets-recall-weak-blister-seals-cause-tablets-to. Based on FDA recall #D-0338-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0338-2026%22&limit=1).

The FDA announced on 2026-01-14 that Amerisource Health Services LLC is recalling Oxycodone Hydrochloride Tablets, USP (CII), 5 mg, 100-Count blister cards due to defective container seals. The weak or non-existent seals can cause tablets to fall out of their cavities.

How to tell if you have it

  • Brand: Amerisource Health
  • Product: Oxycodone Hydrochloride Tablets, USP (CII), 5 mg, 100-Count (10 x 10) blister cards per carton
  • NDC # 10702-018
  • Carton NDC 68084-354-01
  • Blister NDC 68084-354-11
  • Lots #: 1027932, Exp Date 06/30/2027
  • Lots #: 1028360, Exp Date 08/31/2027
  • Distributed by: American Health Packaging, Columbus, Ohio 43217
  • Quantity: 31,676 packages

The hazard

The recall involves defective container card seals that are weak or non-existent. This defect leads to the tablets falling out of their cavities.

Context

GovInfoNow's records show Amerisource Health Services LLC has 30 other recalls on record since 2022-07-27. Recent brand recalls include a 2026-05-01 Primidone Tablets recall for cross contamination risk, a 2026-03-16 Meclizine 12.5mg Tablets recall for failed tablet specifications, and a 2025-10-16 Prazosin Capsules recall due to carcinogenic impurity risk. Other recent recalls of similar products include Preferred Pharma's 2025-11-17 Ondansetron ODT recall due to defective seals, Glenmark's 2025-12-30 Ondansetron Tablets recall for blister packs not fully sealed, and Harvard Drug Group's 2026-02-17 Midodrine tablets recall due to defective packaging.

How to tell if you have this one

Check for 5mg oxycodone tablets in 100-count blister cards per carton with NDC # 10702-018. The packaging was distributed by American Health Packaging with specific lot numbers and expiration dates.

  • Brand
    Amerisource Health Services
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Packaging

    Look for weak or missing blister seals on the 5mg oxycodone tablets in 100-count blister cards.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 35 days after the firm started it.

1. Firm started the recall: Jan 14, 202612. FDA classified it Class II: Feb 13, 202623. Published in FDA’s Enforcement Report: Feb 18, 202632026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Amerisource Health Services recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0338-2026 (January 14, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0338-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA